LUMICELL

LUMICELL

Lumicell illuminates cancer and other diseased tissues at the molecular level, enabling physicians to take action in real-time during surgeries to improve patient outcomes. The company’s lead product is in late-stage development for breast cancer surgery. It features an investigational optical agent and a handheld device that enable cancer surgeons to see and remove cancer cells in real-time during operations.

visit website

*Investment held through Kinled Holding Limited’s Limited Partner status at www.medscienceventures.com

Skills

Posted on

17/11/2019